Company Filing History:
Years Active: 2019-2021
Title: Innovations by William A. Wegener
Introduction
William A. Wegener is an accomplished inventor based in Broomall, Pennsylvania. He has made significant contributions to the field of medical science, particularly in the treatment of hematologic malignancies and autoimmune diseases. With a total of two patents to his name, Wegener's work has the potential to impact many lives.
Latest Patents
Wegener's latest patents include a subcutaneous anti-HLA-DR monoclonal antibody for the treatment of hematologic malignancies. This invention focuses on compositions and methods for using anti-HLA-DR antibodies or fragments to treat patients with hematologic cancer or autoimmune diseases. The subcutaneous administration of these antibodies is designed for patients who have relapsed from or are refractory to standard therapies, such as anti-CD20 antibodies like rituximab.
Another notable patent is for the subcutaneous administration of an anti-CD74 antibody for systemic lupus erythematosus (SLE). This patent discloses methods and formulations for treating autoimmune diseases, specifically SLE, using concentrated formulations of the anti-CD74 antibody, milatuzumab (IMMU-115). The recommended dosage is 250 mg once a week for four weeks, and this method aims to alleviate symptoms of autoimmune diseases with manageable side effects.
Career Highlights
Wegener is associated with Immunomedics, Inc., a company known for its innovative approaches in the field of immunotherapy. His work at the company has been instrumental in advancing treatments for complex medical conditions.
Collaborations
Wegener collaborates with David M. Goldenberg, a notable figure in the field, enhancing the research and development of therapeutic solutions.
Conclusion
William A. Wegener's contributions to medical science through his patents reflect his dedication to improving treatment options for patients with serious health conditions. His innovative approaches have the potential to change the landscape of medical therapies.